Literature DB >> 24792891

RUNX1 point mutations potentially identify a subset of early immature T-cell acute lymphoblastic leukaemia that may originate from differentiated T-cells.

Michelle Meng Huang Mok1, Linsen Du1, Chelsia Qiuxia Wang2, Vinay Tergaonkar3, Te Chih Liu4, Shirley Kow Yin Kham5, Takaomi Sanda1, Allen Eng-Juh Yeoh5, Motomi Osato6.   

Abstract

The RUNX1/AML1 gene is among the most frequently mutated genes in human leukaemia. However, its association with T-cell acute lymphoblastic leukaemia (T-ALL) remains poorly understood. In order to examine RUNX1 point mutations in T-ALL, we conducted an amplicon-based deep sequencing in 65 Southeast Asian childhood patients and 20 T-ALL cell lines, and detected RUNX1 mutations in 6 patients (9.2%) and 5 cell lines (25%). Interestingly, RUNX1-mutated T-ALL cases seem to constitute a subset of early immature T-ALL that may originate from differentiated T-cells. This result provides a deeper insight into the mechanistic basis for leukaemogenesis.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AML1; ETP-ALL; Early immature T-ALL; RUNX1; TCRγ deletion

Mesh:

Substances:

Year:  2014        PMID: 24792891     DOI: 10.1016/j.gene.2014.04.074

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  3 in total

1.  DNMT3A Loss Drives Enhancer Hypomethylation in FLT3-ITD-Associated Leukemias.

Authors:  Liubin Yang; Benjamin Rodriguez; Allison Mayle; Hyun Jung Park; Xueqiu Lin; Min Luo; Mira Jeong; Choladda V Curry; Sang-Bae Kim; David Ruau; Xiaotian Zhang; Ting Zhou; Michael Zhou; Vivienne I Rebel; Grant A Challen; Berthold Gottgens; Ju-Seog Lee; Rachel Rau; Wei Li; Margaret A Goodell
Journal:  Cancer Cell       Date:  2016-06-13       Impact factor: 31.743

2.  Evidence for a role of RUNX1 as recombinase cofactor for TCRβ rearrangements and pathological deletions in ETV6-RUNX1 ALL.

Authors:  V Seitz; K Kleo; A Dröge; S Schaper; S Elezkurtaj; N Bedjaoui; L Dimitrova; A Sommerfeld; E Berg; E von der Wall; U Müller; M Joosten; D Lenze; M M Heimesaat; C Baldus; C Zinser; A Cieslak; E Macintyre; C Stocking; S Hennig; M Hummel
Journal:  Sci Rep       Date:  2020-06-22       Impact factor: 4.379

3.  CTNNA1 hypermethylation, a frequent event in acute myeloid leukemia, is independently associated with an adverse outcome.

Authors:  Mianyang Li; Li Gao; Zhenling Li; Junzhong Sun; Hui Zhang; Haoqing Duan; Yigai Ma; Chengbin Wang
Journal:  Oncotarget       Date:  2016-05-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.